Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development
Ingenix’s Biological Reasoning Engine fuses biological data through Modality Fusion, [...]
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
Financing supports the approval of U.S. Investigational Device Exemption (IDE), [...]
Secretome Therapeutics Announces $30 Million Series A Financing
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy [...]
Ember LifeSciences reports new strategic investments boosting Series A to $27M
The investments follow after they previously announced Series A financing [...]
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery [...]
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand [...]
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
Financing co-led by Taiho Ventures and Arkin Bio Capital with [...]
Wellpoint Invests More Than $2 Million to Strengthen Community-Based Care Across Arizona
Investments support seniors, people with disabilities, family caregivers, and the [...]
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System
FDA breakthrough–designated RESTORE System designed to enable intuitive prosthetic control, [...]
Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
Financing will accelerate the development of proprietary portable diagnostic platform, [...]